3 Amazing Marijuana Stocks That Have Been Flying Under the Radar Until Now

Investing in quality cannabis companies such as Columbia Care will allow you to get outsized gains over the long term.

| More on:

It’s time to forget Canadian cannabis stocks that have grossly underperformed the broader markets for the last two years. Licensed marijuana producers in Canada continue to report heavy losses and tepid top-line growth compared to peers south of the border. Here, we’ll look at three cannabis stocks part of the U.S. markets that are flying under the radar but have massive growth potential.

4Front Ventures

The first stock on my list is 4Front Ventures (CNSX:FFNT), a cannabis producer that aims to use its low-cost cultivation and distribution methods to gain traction in a rapidly expanding market. Founded in 2011, 4Front Ventures has a strong presence in the state of Washington where it is the second-largest player in terms of market share.

In the second quarter of 2021, the company reported sales of US$34.4 million, which were 85% higher than the year-ago period. Its adjusted EBITDA stood at US$7.5 million, indicating a margin of 22%.

4Front Ventures recently completed its state-of-the-art production facility in California that spans 170,000 square feet and is awaiting a licence for the same. It also closed the first phase of a multiphase expansion project of a 558,000-square-feet production facility in Illinois.

With a presence in five states in the U.S., 4Front Ventures can potentially target 76 million people as its customers.

Columbia Care

Valued at a market cap of $1.85 billion, Columbia Care (CNSX:CCHW) is a cannabis cultivator with licences in 18 jurisdictions in the U.S. and European Union. It already operates 130 facilities that include 99 dispensaries and 31 cultivation and manufacturing facilities.

In the second quarter of 2021, Columbia Care reported sales of US$109.7 million, which was an increase of 232% year over year. Its adjusted gross profit rose 300% to US$47.7 million while gross margin stood at a record 43%, compared to 36% in the year-ago period.

Columbia Care reported adjusted EBITDA of US$16.4 million in Q2 compared to an EBITDA loss of US$4.7 million in the prior year quarter. Its stellar quarterly results meant the company’s management reaffirmed revenue guidance between US$500 million and US$530 million with adjusted EBITDA between US$95 million and US$105 million in 2021.

Gage Growth

The final cannabis stock on my list is Gage Growth (CNSX:GAGE), which operates three licensed cultivation and processing centres in Michigan. The cannabis producer grows plants in small batches by using hydroponic cultivation methods.

Michigan is one of the fastest-growing legal cannabis markets in the U.S. where adult-use sales soared 1,070% from January 2020 to April 2021. The state also has over 250,000 medical marijuana patients. In fact, Michigan’s cannabis sales in July stood at US$171 million, which indicates an annualized sales figure of US$2.05 billion, making it the third-largest marijuana market in the U.S.

Gage Growth increased sales by 130.2% year over year to US$26.4 million while gross margin rose to 34.2%, up from 26.1% in Q1 of 2021. A higher gross margin also allowed the company to narrow its EBITDA loss to US$1.9 million from US$3.8 million in the first quarter of 2021.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »